Mitchell E. Taub
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Oncology top 2%
- Drug Transport and Resistance Mechanisms
Papers in
- Oncology 33
- Drug Transport and Resistance Mechanisms 32
- Pharmacology 12
- Pharmacogenetics and Drug Metabolism 12
- Drug-Induced Hepatotoxicity and Protection 3
- Co-authors
- Lalitha Podila (4 shared papers)Sven Frøkjær (7 shared papers)Thomas Ebner (4 shared papers)Maciej J. Zamek‐Gliszczynski (4 shared papers)Rucha Sane (4 shared papers)Bente Steffansen (6 shared papers)Harma Ellens (4 shared papers)Naoki Ishiguro (2 shared papers)
- Journals
- Drug Metabolism and Disposition (14 papers)Pharmaceutical Research (5 papers)International Journal of Pharmaceutics (3 papers)European Journal of Pharmaceutical Sciences (3 papers)Journal of Pharmaceutical Sciences (3 papers)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Mitchell E. Taub
48 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 88
- Pharmacology 361
- Oncology 875
- Pediatrics, Perinatology and Child Health 410
- Pharmaceutical Science 107
- Biochemistry 84
Countries citing papers authored by Mitchell E. Taub
This map shows the geographic impact of Mitchell E. Taub's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell E. Taub with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell E. Taub more than expected).
Fields of papers citing papers by Mitchell E. Taub
This network shows the impact of papers produced by Mitchell E. Taub. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell E. Taub. The network helps show where Mitchell E. Taub may publish in the future.
Co-authors
The 25 scholars most cited alongside Mitchell E. Taub, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 160 | |
| 2 | 2013 | 152 | |
| 3 | 2015 | 108 | |
| 4 | 2005 | 103 | |
| 5 | 2012 | 65 | |
| 6 | 2015 | 59 | |
| 7 | 2002 | 58 | |
| 8 | 2011 | 58 | |
| 9 | 2013 | 56 | |
| 10 | 2001 | 55 | |
| 11 | 1992 | 55 | |
| 12 | 2020 | 45 | |
| 13 | 2018 | 40 | |
| 14 | 2014 | 30 | |
| 15 | 2017 | 28 | |
| 16 | 2013 | 25 | |
| 17 | 2020 | 24 | |
| 18 | 2011 | 22 | |
| 19 | 2014 | 22 | |
| 20 | 1999 | 17 |
About Mitchell E. Taub
Mitchell E. Taub is a scholar working on Oncology, Pharmacology, Molecular Biology, Pediatrics, Perinatology and Child Health and Biochemistry, having authored 52 papers that have together received 1.4k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (32 papers), Pharmacogenetics and Drug Metabolism (12 papers), Amino Acid Enzymes and Metabolism (9 papers), Pharmacological Effects and Toxicity Studies (9 papers), HIV/AIDS drug development and treatment (5 papers), Metabolism and Genetic Disorders (4 papers), Drug-Induced Hepatotoxicity and Protection (3 papers) and Drug Solubulity and Delivery Systems (3 papers). The work is most often cited by research in Pharmacology (361 citations), Oncology (875 citations), Pediatrics, Perinatology and Child Health (410 citations), Pharmaceutical Science (107 citations) and Biochemistry (84 citations). Mitchell E. Taub has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Lalitha Podila, Sven Frøkjær, Thomas Ebner, Maciej J. Zamek‐Gliszczynski, Rucha Sane, Bente Steffansen, Harma Ellens, Naoki Ishiguro, Xiaoyan Chu and Donald Tweedie. Their work appears in journals such as Drug Metabolism and Disposition, Pharmaceutical Research, International Journal of Pharmaceutics, European Journal of Pharmaceutical Sciences and Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.